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Abstract. The purpose of this review is to highlight the role of pituitary adenylate 
cyclase-activating polypeptide (PACAP) in a range of physiological and behavioural 
processes of gastropod molluscs, Helix and Lymnaea. Since its discovery in 1989 
PACAP has become increasingly recognized for its important and diversified roles in 
the central and peripheral nervous system and in several peripheral organs of a variety 
of vertebrate and invertebrate species. Twenty-two years after its discovery, PACAP is 
now one of the most extensively studied of the neuropeptides. This review surveys the 
importance of PACAP and PACAP-like peptides in invertebrates, focusing mainly on 
the gastropod molluscs. The relevance of studies on lower vertebrates and invertebrates, 
which do not have a pituitary gland, is to contribute to the unraveling of fundamental 
effects of PACAP or PACAP-like peptides and to provide a comparative view. 
Pituitary adenylate cyclase-activating polypeptide  
Pituitary adenylate cyclase-activating polypeptide (PACAP) is the member of the growth 
hormone releasing factor (GRF) superfamily 
1
. PACAP was first isolated 22 years ago from 
ovine hypothalamic extract, which had been found to stimulate cAMP formation in anterior 
pituitary cells 
2, 3
. PACAP shows a remarkable amino acid (AA) sequence similarity at the N-
terminal domain across higher and lower vertebrate species (Table 1). Particularly, the first 1-
27 AAs of the peptides N-terminus have been completely conserved in all vertebrate species 
investigated until now, except chicken, stargazer and sturgeon, which have one AA 
substitution at different positions. The sequence similarity is not limited to the peptide 
sequence as the nucleotide sequence similarity is 96% between the human and tunicate 
PACAP-27 cDNAs (Table 2). Such a high degree of sequence homology represents 
conservation over 700 million years of evolution (the estimated time when the stem line 
leading to vertebrates separated from Urochordata) 
1, 4
 and indicates that PACAP fulfills 
important biological functions.  
Table 1. Sequence comparison of vertebrate PACAP peptides 
 
                        * . ******. ** *** :  * * ** ** * ** * ** * : * * :  . * 
human            HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK 
chicken           - I - - - - - - - - - - - - -  - -  - - -  - - -  - -  - - - -  - - -  - -  - - - - 
lizard               - - - -- - - - - - - - - - -  - -  - - -  - - -  - -  - - - -  - - -  - .  . . . . 
frog                 - - - - - - - - - - - - - - - -  -  - - -  - - -  - -  - - - -  - - -  - -  I - - -  
zebrafish         - - - - - - - - I - - - - - -  - -  - - -  - - -  - -  - - - -  - - -  - -  - - - - 
salmon            - - - - - - - - - - - - - - -  - -  - - -  - - -  - -  - - - -  - -  R - - YRS - 
catfish             - -  - - - - - - -  - - - - - - - -  - - -  - - -  - -  - - - R -- R - -FR  - - 
GRRLVVPSVWGIRDWVIWPEKRGKRY 
stingray         - -  - - -  - - - - - - - - - - - -  - -Q  - - -  - -  - - - R – R - - - R - - 
sturgeon          - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - G 
tunicate I        - - - - - - -- - - - - - - N -  - -  - - -  - - - - - - - - -  -  
tunicateII       HSDGIFTDSYSRYRNQMAVKKYINALLGKRYQ 
*, amino acid identity, :, replaceable amino acids 
The discovery of PACAP was soon followed by identification of its receptors in 
different vertebrate species. It is believed that peptide-receptor pairs would have had a 
better chance of survival through evolution if duplication of the ligand and its receptor 
occurred simultaneously. Generally, neuropeptides and their cognate receptors are 
encoded by different genes but their co-evolution is strongly implied in order to 
maintain the system functioning 
5
. The absence of PACAP or PACAP-like receptors in 
tunicates however raises an intriguing question about agonist-receptor co-evolution and 
function in Deuterostomia. The PACAP and vasoactive intestinal peptide (VIP, another 
member of the GRF/secretin/glucagon superfamily) receptors are suggested to have 
arisen only in the vertebrate lineage, probably via genome duplication 
4
. Two types of 
receptors have been characterized according to their relative affinities for PACAP and 
VIP:  PAC1-R and VPAC1 and VPAC2, respectively 
4, 6
. These receptors are members 
of the G-protein coupled receptor family and are unique in the sense that their complex 
genes are able to generate receptor splice variants, which have been reported for all 
three receptor types 
7
.  The PAC1-R is specific for PACAP and the VPAC1 and VPAC2 
receptors are activated by both PACAP and VIP. In vertebrates PACAP and its 
receptors are widely distributed not only in the hypothalamic nuclei, but in the whole 
central (CNS) and peripheral nervous system (PNS) and several organs (eye, different 
glands, gonads, placenta, uterus, respiratory and urogenital tracts, digestive system, 
skin, and muscles) suggesting a broader function to PACAP than the stimulation of the 
pituitary gland 
6, 8, 9, 10, 11
. The physiological effect assigned to the peptide is its ability to 
stimulate the activity of adenylate cyclase (AC). Recently however, owing to the 
involvement of PACAP in an array of physiological functions, the role of the peptide is 
thought to be essential for cell survival. This statement is supported by the observation 
that the majority of PACAP or PACAP receptor knockout animals die 
1, 4, 11, 12
. Studies 
in PACAP knockout animals provide further evidence for the involvement of 
endogenous PACAP in regeneration processes. Upregulation of PACAP following 
nervous injuries has been shown in vertebrates by numerous previous studies 
13
. 
Recently, it has been shown that the concentration of PACAP-like compounds increase 
in regenerating tissues of the earthworm following injury indicating the possible role of 
PACAP in the regeneration 
14
. 
Table 2. mRNA comparison of invertebrate PACAP 
 
AB083650|Hydra             CATTCGGATGGGATCTTCACAGATAGCTACAGCCGCTACCGAAAGCAAAT 50 
AB121759|Halocynthia       CATTCGGATGGGATCTTCACAGATAGCTACAGCCGCTACCGAAAGCAAAT 50 
AB083651|Sepioteuthis      CATTCGGATGGGATCTTCACAGATAGCTACAGCCGCTACCGAAAGCAAAT 50 
AB121765|Eriocheir         CATTCGGATGGGATCTTCACAGATAGCTACAGCCGCTACCGAGAGCAAAT 50 
AB083649|Dugesia           CATTCGGATGGGATCTTCACAGATAGCTACAGCCGCTACCGAAAGCAAAT 50 
AB083652|Periplaneta       CACTCGGATGGGATCTTCACAGACAGCTACAGCCGCTACCGAAAGCAAAT 50 
                           ** ******************** ****************** ******* 
 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAACAAA 114 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAACGAA 114 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAACAAA 114 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAACAAA 114 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAACAAA 114 
     GGCAGTCAAGAAATACCTGGCGGCAGTCCTTGGGAAAAGGTATAGACAGAGATATAGAAGCAAA 114 
     *********************************************************** * **  
 
*-identity 
 
 
GRF-superfamily: VIP, PACAP and related peptides 
 Upon closer examination, peptides with similar structures are frequently observed and 
can be derived from common or different precursors. Sets of peptides with similar AA 
layout are identified and classified into families based on conserved sequence 
homologies, where several members may occur in one species or may extend both inter- 
or intraphyletically 
15, 16
. Identification of peptide families and their members offers an 
insight into phylogenetic relationships and the evolution of neuropeptides and their 
precursor molecules 
12
. The phylogenetic tree shows (Fig.1.) that the variability between 
biologically active PACAP peptides is less that between PACAP and VIP peptide 
families.  
 
Fig.1. – Distance phylogenetic tree from protein sequences of PACAP. For analyzes the 
specific “phyligenetical tree option” of program of Computational Biochemistry 
Research Group (ETH, Zurich, http://www.cbrg.ethz.ch/services/index) was used. 
Evolutionary distances (numbers) were calculated based on 38, 44 or 65 AA sequences 
of PACAP from different vertebrate and invertebrate animals. Sequences were obtained 
from NCBI and ExPASy database: cnidarians – Hydra vulgaris [Q8IU38]; sponge – 
Halocynthia roretzi [Q75W94]; planarian - Dugesia japonica [Q8IU39]; mollusk - 
Sepioteuthis lessoniana [Q8IU37]; cockroach - Periplaneta americana [Q8IU36]; crab - 
Eriocheir japonica [Q75W88]; lizard - Podarcis siculus [ABD77494]; frog1 - Xenopus 
laevis [AAD56956]; frog2 - Rana ridibunda [AAB20402]; ray - Torpedo marmorata 
[ADP00547]; lungfish - Protopterus dolloi [ACI25366]; fish1 - Uranoscopus japonicus 
[P81039]; fish2 - Clarias macrochephalus [CAA55684]; fish3 - Ctenopharyngodon 
idella [ABQ81649]; fish4 - Haplochromis burtoni [ACB29679]; fish5 - Danio rerio 
[AAG59830]; fish6 - Cynoglossus semilaevis [ACM43290]; fish7 - Oncorhynchus 
mykiss [AAK28558]; fish8 - Mola mola [AAV85450]; fish9 - Acipenser schrenckii 
[BAC21154]; fish10 - Trachurus japonicus [BAC21153]; bird - Gallus gallus 
[AAX56089]; sheep - Ovis aries [AAB21469]; bovine - Bos taurus [AAY16443]; rabbit 
- Oryctolagus cuniculus [XP_002713481]; swine - Sus scrofa [NP_001001544]; rat - 
Rattus norvegicus [AAA41791]; mouse – Mus musculus [NP_033755]; human – Homo 
sapiens [AAB21470]; VIP1 - Oncorhynchus mykiss [AAB34607]; VIP2 – Homo 
sapiens [CAI21764]; VIP3 – Bos taurus [DAA26008]; VIP4 – Rattus norvegicus 
[EDL92841]; VIP5 – Mus musculus [AAH89511]. Asterisks  indicate the invertebrate 
animals (bold italic). Dash grey lines indicate the member of VIP peptide family. 
 
The high degree of homology in some examples strongly suggests that the precursors 
were derived from a common ancestral gene. The GRF superfamily provides a good 
example of how gene and exon duplication with tandem insertion led to the evolution of 
a family of related peptides 
17
. The phylogenetic distribution of each peptide is thought 
to be generally restricted within the Protostomia and Deuterostomia groups, because 
neuropeptides have changed with phylogenetic evolution 
18, 19, 20
. However, many 
peptides are widely distributed among several phyla or even between Protostomia and 
Deuterostomia. Examples of this kind of interphyletic distribution are members of the 
oxytocin/vasopressin, tachykinin/substance P, opioid peptides and VIP/PACAP 
families. Members of the GRF superfamily such as VIP, peptide histidine methionine 
(PHM), halospectin (HS), halodermin (HD), and glucagons have also been described in 
the CNS and periphery of Helix and Lymnaea species.  
The cell specific distribution and seasonal variations of these peptides imply that they 
may also act as transmitters, modulators and hormones in the nervous and sensory 
system of gastropods. The presence of PAC1, VPAC1 and VPAC2 receptors has not 
been demonstrated earlier in gastropods due to the high specificity of monoclonal 
antibodies used in these experiments 
21, 22, 23
.  
 
Expression and localization of PACAP and its receptors in molluscs  
 
The primary structure of PACAP has proved to be remarkably conserved during evolution not 
only in higher and lower vertebrates but also in invertebrates. In Table 3 different sequences 
of invertebrate PACAP molecules are aligned with human PACAP using ClustalW2 - 
Multiple Sequence Alignment (http://www.ebi.ac.uk/tool/msa/clustalw2). Detailed analysis 
revealed a high homology (>89 %) of inferred amino acid sequences: 35 AAs are conserved 
at the N-terminus and 3 AAs are variable at the C-terminus. It has been found that the N-
terminus plays a crucial role in the biological activity of the peptide. Site-directed 
mutagenesis has revealed that the N-terminus is essential for receptor activation but is not 
involved in the recognition of the receptor-binding site, which instead seems to involve 
  
Table 3. - Sequence comparison of invertebrate PACAP peptides with human PACAP 
                    
Identity (%) 
 
Q8IU39_DUGJA      HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYRQRYRNK       
Q75W94_HALRO      HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYRQRYRNE       
Q8IU38_HYDMA      HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYRQRYRNK      
Q75W88_EUCA       HSDGIFTDSYSRYREQMAVKKYLAAVLGKRYRQRYRNK      
Q8IU37_SEPLE      HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYRQRYRNK      
Q8IU36_PERAM      HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYRQRYRSK      
PACAP_HUMAN       HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK     
                  **************:****************:** :.: 
 
*- amino acid identity; : - replaceable amino acid 
 
AAs in the C-terminal domain 
6, 24, 25
. The occurrence, localization and distribution of 
PACAP-like peptide and its receptor was recently described in the CNS and peripheral organs 
of gastropods, Helix and Lymnaea. Some nerve fibers in the neuropil and peripheral nerves 
but not the soma of neurons in the CNS were immunostained with PACAP AB 
21
.  Mass 
spectrometric analysis, radio-immune assay (RIA), western-blot (WB) and 
immunohistochemistry revealed the presence of both the 27 and 38 forms of PACAP 
26, 27
. 
The concentration of PACAP27 is significantly higher than PACAP38 in the snail, which 
contrasts to data obtained on mammals, where PACAP38 is the dominant form. However, the 
data obtained in gastropods corresponds well with those obtained in an oligocheta species 
(Lumbricus polyphemus, Eisenia fetida), where the nervous system contains about ten-fold 
higher concentration of PACAP27 than PACAP38 
11, 28, 29, 30, 31
. PACAP-like 
immunoreactivity is observed at very early stages of the embryonic development. It has been 
also found that the clitellum of sexually mature worms contains significantly higher levels of 
PACAP-like immunoreactivity than other regions of the same animals or the clitellum of a 
non-reproducing animal. The observations suggest a role of PACAP or PACAP-like peptides 
in the reproduction and development of invertebrates.  Conversely, only the PACAP38 form 
is present in the CNS of insects 
32
. Unfortunately there is currently no sequence information 
about molluscan PACAP or PACAP-like molecules. It is speculated, that a 14 kDa protein 
band, detected by PACAP27 and PACAP38 antibodies using WB in molluscs represents an 
extended PACAP-like molluscan peptide of larger molecular weight than the vertebrate 4-6 
kDa PACAP molecules. In human prostate and prostate cancer cells however, a 14.6 kDa 
product is described, which likely to be a product of the prePACAP protein (19.9 kDa) that 
has been partially processed by convertases 
33
. The assumption that extended PACAP-like 
molecules may exist is not unique. For example, in lower vertebrates, such as the stingray and 
catfish,  44 and 64 AA long PACAP molecules are observed 
34, 35
. Using the MS/MS 
Fragment Ion Calculator the molecular weight based on sequence could be predicted. The 
average mass of protonated quasimolecular ion ([M+H]
+
) of stingray and catfish PACAP 
would be m/z 5338.25 (5.3 kDa) and m/z 7856.25 (7.8 kDa), respectively. Based on the 
MALDI TOF/TOF measurement similar sequences to PACAP27 and PACAP38 can clearly 
be identified from hemolymph and brain samples of the snail with a molecular weight signal 
of 3147.1 and 4535.2, respectively. Fragments of a PACAP-like molecule are found in Helix 
brain homogenate with an identical AA sequence to mammalian PACAP27 and 38 at 
positions 1-10 and 20-27. The AA sequence at 27-38 differs by only one AA, (an iso-leucine 
to valin substitution) according to the mass calculation. Mass spectra of tryptic digest 
obtained by MALDI-TOF from Lymnaea brain homogenate revealed complete sequence 
similarity of fragments between 1-32 AAs 
26
.  These data confirm the conclusion that PACAP 
is the most conserved member of the GRF peptide superfamily 
6
. Interestingly, the identity of 
the Drosophila amnesiac gene product with human PACAP38 and PACAP27 is only 10% 
and 18%, which is too low to accept as homologue of PACAP in vertebrates. The existence of 
the PACAP and PACAP receptor gene in invertebrates remains to be demonstrated.                                                                                                                                                
The average mass of protonated quasimolecular ion ([M+H]
+
) of synthetic mammalian 
PACAP38 is m/z 4535.47 while in the pond snail, squid, planarian and hydra the hypothetical 
average [M+H]
+
 of the PACAP38-like molecule is m/z 4656.37 (MS/MS Fragment Ion 
Calculator). The reason for this difference could be the three AA differences between 
synthetic mammalian PACAP38 and invertebrate PACAP38-like molecule.                                                                                                                           
The presence of PACAP receptor in invertebrates has only been demonstrated by 
immunological methods so far, and no direct evidence is available for the occurrence of this 
extremely conserved molecule. In snails, similar to vertebrate and other invertebrate species, 
the PACAP acts through a G protein-protein coupled receptor and activate the AC-cAMP 
pathway
26
 . The PAC1-like receptor has been identified in the snail by immunohistochemistry 
and biochemical methods
26, 27
. PAC1-like receptor expressing neuronal elements have been 
observed in the CNS and a number of peripheral organs such as columellar muscle, heart, 
tentacles and epithelial glandular cells. Far western blot experiments revealed three binding 
sites in snail brain homogenate. Two of these corresponded well to the VPAC1 (~45 kDa) and 
PAC1 (~60 kDA) receptors of vertebrates. The observation supports the notion that only one 
type of VIP receptor existed earlier in evolution 
1
. In addition the findings favor the presence 
of specific PACAP receptors, the PAC1-like and VPAC1-like receptors in the snail, which 
however should be isolated and sequenced.  
 
Functions of PACAP in molluscs  
Neuropeptides have different activities that are dependent on the target tissue, 
developmental stage or interactions with other modulators. In vertebrates PACAP and 
its receptors are widely distributed in different tissues and cells. They are also involved 
in numerous physiological functions and regulator of metabolism in the nervous, 
endocrine, cardiovascular, and muscular and the immune system 
1, 4
. The wide 
distribution of PACAP and its receptors suggests that the peptide may exert pleiotropic 
physiological functions 
6
. Several good reviews discuss the physiologic effects of 
PACAP in vertebrates 
1, 11, 36, 37
. In contrast in this review we would like to focus on the 
data obtained so far on molluscs. The high structural conservatism and interphyletic 
distribution of PACAP and its receptor molecules suggest that this peptide could also be 
involved in the regulation of several basic physiological functions in snails similar to 
those observed in vertebrates.  
Antiapoptotic effect 
 Recently it was shown for the first time, that PACAP has an anti-apoptotic effect in the 
salivary gland cells of the snail 
38
. In several gastropod species saliva or mucus release 
is performed by the holocrine release mechanism leading to cell destruction 
39, 40
. It has 
been suggested that cell death is indeed the physiological method of saliva release 
which takes place through a form of programmed cell death that is regulated by 
transmitters. Indeed, it has been observed that stimulation of the salivary nerve or 
external application of dopamine elicits a change of mitochondrial membrane potential, 
and translocation of cytochrome-c from mitochondria to the cytoplasm typical for the 
intrinsic mitochondrial pathway of programmed cell death 
41, 42
. It has been observed 
that PACAP significantly attenuates the dopamine- and colchicine–induced apoptosis. 
The anti-apoptotic effect of PACAP on vertebrate neuronal and non-neuronal cells is 
well documented 
8, 9, 43, 44
. The protective effects of PACAP are based on the capacity of 
the peptide to prevent apoptosis by acting directly on caspases and Bax or indirectly 
through the release of cell-protective factors by astrocytes. The anti-apoptotic effect of 
PACAP is mediated by PAC1 receptor 
44
. These results imply that the anti-apoptotic 
effect of PACAP may be one of the basic functions of the peptide through evolution; 
both the peptide structure and this function have been conserved.  
Possible role in hibernation 
 In active snails the level of PACAP is fourfold higher compared to the brain of 
hibernating snails, as revealed by immunohistochemistry and radioimmunoassay 
analysis 
27
. Terrestrial snails possess a variety of behavioural, physiological and 
biochemical adaptation strategies to overcome unfavourable environmental conditions 
45
. The overall depression of metabolic rate is a general strategy for animals during 
hibernation. Evidence showing PACAP is a metabolic regulator makes it an ideal 
candidate for a role in hibernation. Since PACAP is considered to be a metabolic 
regulator its participation in hibernation is suggested. Whether the observed decrease in 
PACAP is a consequence of the overall hypometabolism typical for hibernating 
animals, or is indicative of  a decisive role in regulating the hibernated state is still an 
unanswered question 
46
. Seasonal changes in the other members of the GRF superfamily 
have also been observed. For example hibernating snails (Helix) contain higher numbers 
of VIP immunoreactive neurons than active animals 
21
. It is speculated that peptides 
present at higher expression levels or maintained exclusively in a particular state might 
contribute of a physiological fate which may be to either attenuate 
46, 47
. However, 
expression level alone is not necessarily an indicator of any given peptide’s immediate 
participation in establishing the physiology.  It could be simply be a reduced metabolic 
rate and increased intensity as a consequence of a decreased release.  
Effect on ion channel function  
 In snail neurons expressing PAC1-like receptors PACAP27 and PACAP38 elicit 
membrane potential changes (both hyperpolarisation and depolarisation) leading to 
changes in action potential frequency. PACAP6-38, a specific PACAP-R antagonist, 
powerfully antagonizes the membrane effect of PACAP 
27
. These results may suggest 
that PACAP is directly able to modulate the ion channels responsible for membrane and 
action potential generation. Indeed, in insect larval muscles PACAP enhances K
+
-
current and modulates L-type Ca
2+
-current via cAMP-PKA pathway 
32, 48
. PACAP-like 
peptide has been identified in the insect Drosophila melanogaster 
49
, and this peptide 
has been found to modulate ionic conductance at the neuromuscular junction
32
 .   In 
human pituitary adenoma cells PACAP can activate voltage dependent tetrodotoxin 
sensitive Na
+
-channels via the adenylate cyclase protein kinase A pathway 
50
. The effect 
is antagonized by PACAP6-38 showing that the effect of the peptide is mediated by its 
specific receptor. In mouse olfactory epithelia PACAP reduces the expression of Kv1.4 
and Kv4.1 channel subunits underlying A-type current. PACAP induced reduction of A-
type K
+
-channels is completely blocked by a phospholipase C pathway antagonist, 
however the channel is still dowregulated by PACAP when the cAMP pathway is 
inhibited 
51
. The results available to date suggest that PACAP changes ion channel 
activity directly or via a down regulation of mRNA expression.       
Effect on secretion 
In vertebrates, the salivary gland is innervated by PACAP containing neurons of the 
parasympathetic ganglia 
1
. In order to study the stimulus-secretion mechanism, the 
salivary gland in snails is highly amenable 
52
 but surprisingly, PACAP immunoreactive 
nerve fibres are not detected in the snail; PACAP immunopositivity is localized 
exclusively to certain types of gland cells.  In addition, PACAP or PACAP-like 
receptors have not been found in snail salivary gland with the antibody used in 
experiments to date 
38
. Despite it is observed that PACAP increases the cAMP 
concentration in the homogenate of snail salivary glands and it protects cells from 
apoptosis: however its exact role in secretion remains largely unknown.   
The role of PACAP in learning and memory  
 The molluscan homologue of PACAP is found to be necessary for the aquisition and 
consolidation of long-term memory in the snail. It has been demonstrated, that systemic 
application of exogenous PACAP accelerates the formation of transcription-dependent 
memory during single trial reward chemical or multiple aversive tactile conditioning in 
Lymnaea. Using the PACAP6-38 antagonist it has also been shown that the memory 
accelerating effect of PACAP is dependent on G-protein coupled PAC1-like receptors 
53
.These observations are not altogether surprising because previous behavioral studies 
on vertebrates have found that PACAP is necessary but not sufficient for memory 
formation and consolidation 
54, 55, 56
. 
Conclusion:  
The presence of PACAP-like sequences in of molluscs establishes the origin of the 
PACAP/glucagon superfamily in invertebrates. The protochordates are the major group 
from which the vertebrates are thought to have arisen. In tunicates a cDNA has been 
identified that encodes the PACAP-27 but not the extended PACAP-38 
1
. Based on 
these observations it is suggested that PACAP27 could have been the first molecular 
form  to evolve 
1
. Although the existence of PACAP receptors have not been identified 
and sequenced in invertebrate animals their existence is highly suggested. Considering 
the data obtained in invertebrates an earlier appearance or parallel evolution of the 
PACAP38 molecule could be implicated. The Eukaryota Tetrahymena is a free-living 
ciliate protozoa widely used as an animal model in biological and biomedical research 
and exhibits a behavioural avoidance to PACAP-38. PACAP has been observed to act 
through a common AC activating pertussis sensitive G-protein receptor. However, the 
pharmacological profile of the receptor is different from known PACAP-R in other 
systems. For example, the antagonists PACAP 6-27 and 6-38, which competitively 
inhibit many PACAP receptors actually serve as agonists for Tetrahymena 
57
. PACAP-
like peptides are also reported in cnidarians and other Protostomia, their function has 
been demonstrated but identification of the receptor is missing 
58
. The possibility cannot 
be excluded that PACAP is able to exert its action by directly activating the AC 
penetrating the cell membrane. Certainly, more studies on invertebrates, regarding both 
the molecular structure and function of peptides and receptors will largely provide an 
important contribution to establishing the evolutionary origin of PACAP. 
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